NASDAQ · BIB
ProShares Ultra Nasdaq Biotechnology
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
Loading market information…
AMEX · SNTH · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
MRP SynthEquity ETF’s quoted price sits in the lower half of its reported 52-week range, 16.68% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
MRP SynthEquity ETF’s forward annual dividend is $0.68 per share, paid quarterly. The forward yield is 2.35% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE COMPANY BEHIND THE TICKER
The MRP SynthEquity ETF operates as an actively managed exchange-traded fund. It pursues its investment goals through a dual strategy, utilizing both options contracts and U.S. Treasury securities. The fund's primary objective is capital appreciation, which it aims to achieve by investing in S&P 500 Index options designed to function as synthetic representations of the index. Notably, this fund does not employ a diversified investment approach.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 02:06 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
$36.40-$0.34 (-0.93%)
iShares LifePath Target Date 2035 ETF’s quoted price sits in the upper half of its reported 52-week range, 3.09% below the high.
$37.29-$1.07 (-2.8%)
Rareview Systematic Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 7.65% below the high.
$39.96-$0.80 (-1.97%)
Tema Durable Quality ETF’s quoted price sits in the upper half of its reported 52-week range, 4.87% below the high.
$40.84-$0.41 (-0.99%)
Pacer Swan SOS Flex (January) ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$38.37-$1.45 (-3.63%)
Innovator Growth Accelerated ETF - Quarterly’s quoted price sits in the lower half of its reported 52-week range, 8.81% below the high.
$39.89-$0.51 (-1.25%)
Innovator Buffer Step-Up Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 2.07% below the high.
$30.32-$0.11 (-0.36%)
FT Vest U.S. Equity Buffer & Premium Income ETF - September’s quoted price sits in the upper half of its reported 52-week range, 0.95% below the high.
